MENU
GHRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
GH Research (GHRS) Ownership - Who owns GH Research?
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression... Show more
Profile
Industry
N/A
Address
Dawson Street
Phone
+353 14378334
Employees
49
Web
https://www.ghres.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
796.44M
P/E Ratio
N/A
Total Cash
291.35M
Projected Growth
N/A
Total Debt
658K
Revenue
N/A
Risk (Beta)
0.56
Dividend Yield
N/A
Total Cash/Share
4.70
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GHRS
Capitalization
796M
P/E Ratio
N/A
Risk (Beta)
0.56
Dividend Yield
N/A
Total Cash
291M
Total Cash/Share
4.70
Total Debt
658K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
310M
P/B Ratio
2.57
Cash Flow
N/A
Earnings
-0.79
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.55M
Current Ratio
29.71
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-41.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-15.65
Shares Held By Institutions
231M
Shares Outstanding - Current
62M
Total Liabilities
10.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
83.429
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Dawson Street
Phone
+353 14378334
Employees
49
Web
https://www.ghres.com